News
JSR Life Sciences Amsphere A3 Leveraged in FDA-Approved Antibody Therapy
JSR Life Sciences, LLC’s lead product, Amsphere A3 has been incorporated for the first time into the commercial manufacturing of an FDA-approved treatment.
Amsphere A3 is a next-gen Protein-A chromatography resin that enables advanced protein separation in downstream processing of...
Clinical Trials
Calyx Selected by ProTrials as Partner for Improving Clinical Trial Outcomes Data
Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an approved partner by ProTrials Research, Inc., a mid-sized full-service clinical research organization (CRO) specializing...
News
Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
FUJIFILM Corporation announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life science research, bioproduction, and cell therapy manufacturing, will acquire Shenandoah Biotechnology, Inc., a...
News
GMP certification for Exothera further expands its viral vector manufacturing capacity
Exothera S.A., a CDMO specialized in the development and manufacture of viral vectors for vaccines and gene therapies, received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products (FAMHP) for its facilities in Jumet,...
News
Wockhardt-Serum Institute of India Bond For Vaccines In UK
Wockhardt, located in India, and a Serum Institute of India affiliate have agreed to develop a new fill-finish production facility in Wrexham, North Wales (PDF). Financial information, as well as data on the initiation of the project, the size...
News
Germany Vaccine Output To Surge By $3.14 Billion By 2029
BioNTech and CureVac, two German mRNA companies, have agreed to offer Germany with vaccines for future medical catastrophes for the next many years. Reuters reported that Germany would pay up to 2.86 billion euros ($3.14 billion) to tie in...
News
Exodus of Companies From Russia Due To The Ukrainian War
Hundreds of businesses have announced a suspension or withdrawal of operations in Russia since its invasion of Ukraine. Some of the most recent companies to join the increasing list were Eli Lilly, Novartis, and AbbVie.
Eli Lilly has halted the sale...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read